Kristen Kucharczuk, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 701 Montgomery Ave, Suite 18, Penn Valley, PA 19072 Phone: 610-642-9200 Fax: 610-649-4723 |
News Archive
The Teen Project and Fostering Dreams through Dance partner up to bring the Flash Mob phenomenon to Venice Beach and raise awareness about homeless youth exiting foster care.
Genesis Biopharma, Inc., a biotechnology company developing targeted cancer therapies, today announced that it closed private offerings in December and October 2010 pursuant to which it entered into definitive agreements with accredited investors to purchase a total of 845,000 shares of the Genesis Biopharma common stock for a purchase price of $1.00 per share.
Screening lung cancer tumor samples for cancer-causing, or "driver," genetic mutations can help physicians tailor patients' treatments to target those specific mutations. While scientists have identified cancer-causing mutations for the majority of lung adenocarcinomas — the most common type of non-small cell lung cancer — and have developed drugs that can successfully address them, scientists have not yet identified targeted therapies for another type of non-small cell lung cancer known as squamous cell carcinoma.
Migraine is one of the most common neurological disorders and it affects 1 out of 7 people in the world. Painful and incapacitating, it has multi-factor origins, with the participation of environmental triggering factors and several altered genes in each individual.
Identical twins with autism spectrum disorder often experience large differences in symptom severity even though they share the same DNA, according to an analysis funded by the National Institutes of Health.
› Verified 6 days ago